… Head and neck cancer represents $ 5% of all cancers and >… Approximately 60–65% of patients
with head and neck cancer can … The great majority (>90%) of head and neck cancer in the …

… and to respond better to treatment. This review is limited to head and neck cancers of
squamous cell histology, which constitute more than 90% of head and neck cancers. Because …

… of Cancer for the past 6 decades. This review focuses on the evolution of treatment approaches
for head and neck cancer and … Cancer 2008;113(7 suppl):1911–32. © 2008 American …

… and review the current treatment options for head and neck cancers, including the emerging
… Surgery remains the primary treatment strategy for oral cavity head and neck cancers. Oral …

… and treatment may negatively influence oncologic and/or functional outcomes in head and
neck cancer (… This systematic review aims to provide insight into the effects of time to treatment …

… for radiation treatment programmes considering adopting this … two-dimensional EBRT if
treatment-related outcomes are the … IMRT in the treatment of recurrent head and neck cancer, as …

… involved structures dictate that the goals of treatment are not only to improve survival outcomes
… curative treatment of locally advanced squamous-cell carcinoma of the head and neck. In …

… from the firstline Treatment of Recurrent or Metastatic Head and Neck Cancer trial. Cetuximab
… -line treatment of recurrent or metastatic disease, and in second-line treatment of platinum-…

… issue in head and neck cancer. Explanation of factors predicting QOL after treatment has
important … In this prospective study we analyzed which pretreatment factors predicted QOL after …

Patients undergoing radiation therapy for head and neck cancer (HNC) experience significant
early and long-term side effects. The likelihood and severity of complications depends on …